×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Faculty of Healt... [2]
Institute of Chi... [1]
THE STATE KEY LA... [1]
Authors
KWOK HANG FAI [1]
HU HAO [1]
UNG OI LAM CAROL... [1]
Document Type
Journal article [3]
Date Issued
2024 [1]
2022 [1]
2019 [1]
Language
英語English [3]
Source Publication
Current protein ... [1]
International Im... [1]
Proceedings of t... [1]
Indexed By
SCIE [3]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-3 of 3
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Title Ascending
Title Descending
Issue Date Ascending
Issue Date Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Author Ascending
Author Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
Real-world treatment patterns and outcomes for patients with advanced hepatocellular carcinoma initially treated with PD-1 inhibitors
Journal article
Zou, Huimin, Ge, Ying, Chen, Wenge, Yao, Dongning, Oi Lam Ung, Carolina, Lai, Yunfeng, Hu, Hao. Real-world treatment patterns and outcomes for patients with advanced hepatocellular carcinoma initially treated with PD-1 inhibitors[J]. International Immunopharmacology, 2024, 132, 111947.
Authors:
Zou, Huimin
;
Ge, Ying
;
Chen, Wenge
;
Yao, Dongning
;
Oi Lam Ung, Carolina
; et al.
Favorite
|
TC[WOS]:
0
TC[Scopus]:
1
IF:
4.8
/
5.0
|
Submit date:2024/05/16
Hepatocellular Carcinoma
Programmed Cell Death Protein-1 Inhibitor
Tislelizumab
Camrelizumab
China
An analgesic peptide H-20 attenuates chronic pain via the PD-1 pathway with few adverse effects
Journal article
Zhao, Long, Luo, Hao, Ma, Yu, Zhu, Shengze, Wu, Yongjiang, Lu, Muxing, Yao, Xiaojun, Liu, Xin, Chen, Gang. An analgesic peptide H-20 attenuates chronic pain via the PD-1 pathway with few adverse effects[J]. Proceedings of the National Academy of Sciences of the United States of America, 2022, 119(31).
Authors:
Zhao, Long
;
Luo, Hao
;
Ma, Yu
;
Zhu, Shengze
;
Wu, Yongjiang
; et al.
Favorite
|
TC[WOS]:
11
TC[Scopus]:
13
IF:
9.4
/
10.8
|
Submit date:2023/01/30
Analgesic
Chronic Pain
Dorsal Root Ganglion
Programmed Cell Death Protein 1
Src Homology 2 Domain–containing Tyrosine Phosphatase 1
Targeting PD-L1 Protein: Translation, Modification and Transport
Journal article
Wei R., Guo L., Wang Q., Miao J., Kwok H.F., Lin Y.. Targeting PD-L1 Protein: Translation, Modification and Transport[J]. Current protein & peptide science, 2019, 20(1), 82-91.
Authors:
Wei R.
;
Guo L.
;
Wang Q.
;
Miao J.
;
Kwok H.F.
; et al.
Favorite
|
TC[WOS]:
22
TC[Scopus]:
23
IF:
1.9
/
3.0
|
Submit date:2018/12/19
Immunotherapy
Modification
Programmed Cell Death Protein 1 (Pd-1)
Programmed Death Ligand 1 (Pd-l1)
Translation
Transport.